metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology
Annals of Hepatology
ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), Science Citation Index Expanded (SCIE), SCImago Journal Rank (SJR), SNIP

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more
Impact factor 2023
3.7
Citescore

CiteScore measures average citations received per document published.

See more
Citescore 2023
7.9
SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more
SJR 2023
0.289
SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
SNIP 2023
0.941
View more metrics
Hide
Last published articles
Original article
Body mass index and diabetes predict severity of liver fibrosis across the spectrum of steatotic liver disease
Eda Kaya, Eduardo Vilar-Gomez, Raj Vuppalanchi, Yusuf Yilmaz
Full text access
Original article
Clinical spectrum and long-term outcomes of non-cirrhotic portal venous system thrombosis in Hispanic population
Fernando Gil-López, Fausto Alfredo Rios-Olais, Roberta Demichelis-Gomez, Angel Vargas-Ruiz, Analy Mora-Cañas, Lydia A. Mercado, Denise M. Harnois, Juan Rangel-Patiño
Full text access
Letters to the editor
Metabolic dysfunction and kidney disease risk in individuals with MAFLD
Ziyan Pan, Mohammed Eslam
Full text access
Latest issue
Issue
portada-S1665268124X00083Vol. 30. Issue 2. (In progress)
(July - December 2025)
This issue is in progress but contains articles that are final and fully citable.
Concise reviews
Is the liver resilient to the process of ageing?
Nirupama Chatterjee, Rishabh Sharma, Pratibha R Kale, Nirupma Trehanpati, Gayatri Ramakrishna
Full text access
Latin American association for the study of the liver (ALEH) guidance on postoperative care after liver transplantation
Liana Codes, Rodrigo Zapata, Manuel Mendizabal, Alfeu de Medeiros Fleck Junior, Juan Carlos Restrepo, Leonardo de Lucca Schiavon, Luiz Marcelo Sá Malbouisson, Wellington Andraus, ... members of ALEH Special Interest Group on Liver Transplantation
Full text access
Treatment for hepatocellular carcinoma after immunotherapy
Landon L. Chan, Tsz Tung Kwong, Johnny C.W. Yau, Stephen L. Chan
Full text access
View latest issue View all issues
Ahead of print

Ahead of print are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info

Incidence and predictors of non-hepatic cancers in biopsy-proven alcohol-related liver disease
Mayur Brahmania, Zaid Hindi, Nancy Shi, Juan Pablo Arab, Neil Rajoriya, Guruprasad P. Aithal, Michael Allison, Hannes Hagström, ... WALDO investigators
Full text access
Uncorrected Proof. Available online 17 April 2025
Comment on “MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease”
Ying Ma, Na Lv, Fang Bai
Full text access
Uncorrected Proof. Available online 2 April 2025
Future directions of stem cell therapy for liver failure: Insights from a meta-analysis
Shenglong Lin, Haibing Gao, Yueyong Zhu
Full text access
Uncorrected Proof. Available online 2 April 2025
View all Ahead of print
All issues
portada-July - December
July - December
Volume 30 . Issue. 2
In progress
portada-January - June
January - June
Volume 30 . Issue. 1
In progress
portada-November - December
November - December
Volume 29 . Issue. 6
portada-September - October
September - October
Volume 29 . Issue. 5
View all issues
Supplements
portada-December
December
Volume 29. Issue. S3
Abstracts of the 2024 Annual Meeting of the ALEH
portada-February
February
Volume 29. Issue. S2
Abstracts Asociación Mexicana del Hígado (AMH) 2023
portada-February
February
Volume 29. Issue. S1
Abstracts of the 2023 Annual Meeting of the ALEH
portada-March
March
Volume 28. Issue. S1
Abstracts of the 2022 Annual Meeting of the ALEH
View all supplements
Instructions for authors
Most often read
Manuel Mendizabal, Guilherme Grossi Lopes Cançado, Agustín Albillos
10.1016/j.aohep.2023.101180
Ann Hepatol. 2024;29:
This article has been read 11.500 times
View all Most Often read articles
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos